Request for Covid-19 Impact Assessment of this Report
Neurology is responsible for treatment related to nervous system. Interventional neurology is a new procedure used for the non-surgical treatment of neurological diseases. It has a wide range of application in diagnosis of central nervous and peripheral systems.
End-user/ Technology
Hospitals, medical healthcare centers, and neurology clinics are the primary users. Interventional neurology is a modern technique that uses image-guided diagnosis and treatment of complex nervous system disorders related to arteries and veins of brain, neck, and spine. This is a minimally invasive procedure which reduces the chance of infection and also helps in fast healing and recovery.
Market Dynamics
Advancement in technology, rising need for less invasive surgical procedures, the aging population, improvement of healthcare infrastructure, rising frequency for brain stroke, increasing rate of accidents causing brain injuries are the main driving force for the growth of the global interventional neurology market. R&D funding from Govt. and non-government agencies for technical advancement in brain monitoring devices is helping the market to expand. On the other hand lack of awareness among people, insufficiently trained professionals, high cost, and stringent Govt. regulations are some of the primary restraints.
Market Segments
The market can be segmented based on product, technique and disease pathology. The product market can be subdivided into aneurysm coiling and embolization devices (i.e. flow diversion devices, embolic coils), angioplasty and stenting devices, neuro thrombectomy and micro support devices. Cerebral angiography, neuro thrombectomy method are some of the well-used techniques. The disease pathology market is further segmented into ischemic strokes, brain aneurysm, arteriovenous malformation, artery stenosis etc.
Regional/Geographic Analysis
North America is the market leader followed by Europe and the Asia Pacific. Technological advancement, venture capital investment, govt support and increasing demand ensure North America's leadership in the interventional neurology market. High purchasing power and disposable income in North America and Europe also ensure the market growth. Investors and manufacturers are highly interested in Asia Pacific regions due to the presence of untapped market with lots of opportunities. Other geographic markets include South America, Japan, and Middle East & Africa.
Opportunities
Technological advancement, Govt. support and increasing awareness among people are creating lots of opportunities in the current market. The highest growth rate is expected to be in the Asia Pacific region in the forecasted period. Various R&D work in critical disease sector and complex surgical procedures are also creating opportunities for the market to grow.
Key Players
Some of the major players in the market include Stryker, TERUMO CORPORATION, Medtronic, Covidien, Merit Medical Systems, Inc., Abbott, Johnson & Johnson Services Inc., Bayer AG, MicroPort Scientific Corporation, Medikitco, Ltd., W. L. Gore & Associates, Inc., LLC, Boston Scientific Corporation, and Sequent Medical.
Report Contents:
> Market segments
> Market Drivers, Restraints and Opportunities
> Market Size & Forecast 2016 to 2022
> Supply & Demand Value Chain
> Market - Current Trends
> Competition & Major Companies
> Technology and R&D Status
> Porters Five Force Analysis
> Strategic and Critical Success Factor Analysis of Key Players
Regional Analysis:
> North America
>> US and Canada
> Latin America
>> Mexico, Brazil, Argentina and Rest of Latin America
> Western Europe
>> EU5 (Germany, France, Italy, Spain, U.K.)
>> Nordic Countries (Denmark, Finland, Norway, and Sweden)
>> Benelux (Belgium, The Netherlands, and Luxembourg)
>> Rest of Western Europe
> Eastern Europe
>> Russia
>> Poland
>> Rest of Eastern Europe
> Asia Pacific
>> China
>> India
>> Japan
>> Australia and New Zealand
>> Rest of Asia Pacific
> Middle East and Africa
>> GCC countries (Saudi Arabia, Oman, Qatar, Bahrain, UAE and Kuwait)
>> South Africa
>> North Africa
>> Rest of Middle East and Africa
This report is an elaborate aggregation of primary inputs from industry experts and participants across the supply chain. It provides details on market segmentation which is derived from several product mapping exercises, macroeconomic parameters and other qualitative and quantitative insights. The impact of all such factors is delivered across multiple market segments and geographies.
Report Highlights:
> Detailed Historical Overview (Market Origins, Product Launch Timeline, etc.)
> Consumer and Pricing Analysis
> Market dynamics of the industry
> Market Segmentation
> Estimated Market Sizing in terms of volume and value
> Recent trends in Market and impact
> Research Status and Technology Overview
> Extensive Industry Structure Coverage
Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...
Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...
The pharmaceutical agents that are administered to treat, diagnose, and prevent life-threatening diseases (rare diseases) are known as orphan drugs. The global orphan drugs market accounted for $106 billion in 2015, and is anticipated to reach $169 billio...